相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors
Akira Fukutomi et al.
INVESTIGATIONAL NEW DRUGS (2012)
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia
Mark J. Bishton et al.
BLOOD (2011)
Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes
C. R. Giver et al.
LEUKEMIA (2011)
Phase I Study of Vorinostat in Patients With Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Peter Atadja
CANCER LETTERS (2009)
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors
H. Miles Prince et al.
FUTURE ONCOLOGY (2009)
Histone Deacetylase Inhibitors in Cancer Therapy
Andrew A. Lane et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
Guenther H. S. Richter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
Leah A. Owen et al.
PLOS ONE (2008)
Mechanisms of HDAC inhibitor-induced thrombocytopenia
Hideaki Matsuoka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy
Ricky A. Sharma et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies
Francis Giles et al.
CLINICAL CANCER RESEARCH (2006)
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors
R Sakimura et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein
F Nakatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
